ABBOTT PARK, Ill., Oct. 19, 2017
/PRNewswire/ -- Science has spoken: Abbott (NYSE:
ABT) is, again, among the best science-based companies to work
for in the world.
For the 14th year, the journal Science today
recognized Abbott on its Top Employers list, which is based on an
evaluation of 23 characteristics including financial strength, easy
adaptation to change, and a research-driven environment.
At Abbott, scientists develop life-changing technologies that
help people live their best lives through good health. From freeing
people with diabetes from routine finger sticks1, to
building a cardiac device to save lives, to hunting for new virus
mutations, every day Abbott employees are doing work that
matters.
"Abbott's diverse businesses and product lines open up exciting
career opportunities for our scientists across a range of
technologies," said John Frels,
Ph.D., chair of Abbott's Scientific Governing Board, which oversees
the company's senior scientific career track.
"We strive to foster a culture of innovation and collaboration
within our teams and in our work with others to gain fresh
perspectives and further inspire our scientists to continue to push
the boundaries on scientific advancements. This contributes to a
strong, vibrant and fulfilling environment for scientists to
develop their careers – and supports Abbott's long, successful
legacy of scientific achievement and game-changing technology."
Our spirit of innovation and relentless focus on pushing the
frontiers of science have allowed our company to thrive for more
than 125 years. Today, we're working tirelessly to carry on that
great legacy and to address some of healthcare's greatest
challenges.
Some of Abbott's latest breakthroughs include:
- A unified family of innovative next-generation diagnostics
systems across lab disciplines that offer more efficiency,
flexibility and confidence to health systems, and better help
doctors and nurses get the results they need to improve
decision-making and patient care.
- Our revolutionary diabetes technology that replaces blood
glucose monitoring, freeing people with diabetes from the pain and
hassles of routine fingersticks.
- Pioneering neuromodulation technology that can transform
quality of life for many people who are otherwise unable to find
relief from their chronic pain, while also reducing or stabilizing
opioid use among patients battling chronic pain conditions.
- A first-of-its-kind cardiac device that has transformed the
treatment of certain kinds of mitral regurgitation (MR) for people
who are too frail for open-heart surgery or those who are not
candidates for surgery.
- Groundbreaking research that has helped bring infant formula
closer than ever to breast milk.
ABOUT THE 2017 SCIENCE SURVEY
The 2017 Science survey sought to identify the companies
with the best reputations as employers. The findings are based on
6,950 completed surveys from readers of Science and other
survey invitees. Survey respondents came from North America (65%), Europe (25%) and Asia/Pacific Rim (7%); 94% work in biotechnology,
biopharmaceutical and pharmaceutical companies. Here's a complete
list of the rankings, which also are available in the Oct. 20, 2017 print edition of
Science.
ABOUT ABBOTT
At Abbott, we're committed to helping you live your best
possible life through the power of health. For more than 125 years,
we've brought new products and technologies to the world – in
nutrition, diagnostics, medical devices and branded generic
pharmaceuticals – that create more possibilities for more people at
all stages of life.
Today, 94,000 of us are working to help people live not just
longer, but better, in the more than 150 countries we serve.
Connect with us at www.abbott.com, on Facebook at
www.facebook.com/Abbott and on Twitter @AbbottNews and
@AbbottGlobal.
1 A finger prick test using a blood glucose meter is
required during times of rapidly changing glucose levels when
interstitial fluid glucose levels may not accurately reflect blood
glucose levels or if hypoglycaemia or impending hypoglycaemia is
reported by the system or when symptoms do not match the system
readings.
View original content with
multimedia:http://www.prnewswire.com/news-releases/a-great-place-to-do-great-things-developing-game-changing-technology-at-abbott-300540109.html
SOURCE Abbott